Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study

Fig. 1

LAG3 mRNA expression analysis in multiple cancers Comparison of LAG3 mRNA expression between tumor and normal tissue in various human cancers with TIMER to visualize and analyze data from TCGA and analysis using the Wilcoxon rank-sum test. LAG3 mRNA expression was higher in breast cancer, esophageal cancer, head and neck cancer, kidney clear cell carcinoma, lung adenocarcinoma, and lung squamous cell carcinoma than in normal tissues. However, LAG3 mRNA expression was lower in colon cancer, kidney chromophobe, liver cancer, prostate cancer, rectal cancer, thyroid cancer, and endometrioid cancer than in normal tissues. Red: tumor, Blue: normal tissue, ***P < 0.001, **P < 0.01, *P < 0.05

Back to article page